Symbol
|
Z08W6Z | YYALTQ | Z095OZ | Z0972Z | Z0974Z | Z0973Z | EQTRCH |
---|---|---|---|---|---|---|---|
Nom | Autocallable Reverse Convertible Defensive worst | Multi Reverse Convertible | Autocallable Reverse Convertible Defensive worst | ZKB Reverse Convertible on worst of Last Look | ZKB Reverse Convertible on worst of Last Look | ZKB Reverse Convertible on worst of Last Look | Worst of Callable Reverse Convertible |
Sous-jacent
|
Bristol-Myers Squibb Co. / Johnson & Johnson / Procter & Gamble Co. | Abbott Laboratories / Bristol-Myers Squibb Co. / Medtronic Inc. | Bristol-Myers Squibb Co. / Pfizer Inc. / UnitedHealth Group Inc. | Bristol-Myers Squibb Co. / Pfizer Inc. / Roche GS | Bristol-Myers Squibb Co. / Pfizer Inc. / Roche GS | Bristol-Myers Squibb Co. / Pfizer Inc. / Roche GS | Amazon.com Inc. / Bristol-Myers Squibb Co. / Nike Inc. |
Emetteur
|
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Échéance
|
20.03.2025 | 15.01.2025 | 28.08.2025 | 04.03.2026 | 04.03.2026 | 04.03.2026 | 05.12.2025 |
Ratio | - | - | - | - | - | - | - |
Prix d'exercise
|
107,4951 | 42,6728 | 401,2162 | 189,578 | 189,578 | 189,578 | 108,9257 |
rendement max. p.a. | 6,53% | 9,18% | 6,33% | 7,56% | 10,85% | 9,50% | 5,06% |
Demande | 100,10 | 99,40 | 100,77 | 103,70 | 105,12 | 104,45 | 100,11 |
Offre | 100,80 | 100,20 | 101,47 | 104,20 | 105,62 | 104,95 | 100,91 |